--- description: Autoimmune advocates met with lawmakers to push for health insurance reform, lower medication costs, and increased research funding on Capitol Hill. title: Autoimmune Advocates Push for Health Insurance and Research Reform on Capitol Hill image: https://autoimmune.org/wp-content/uploads/2026/03/project-3-scaled.jpg --- [Skip to content](#content) [Donate](https://autoimmune.org/blog/autoimmune-advocacy-capitol-hill-reform/?campaign=697841) March 30, 2026 0 Share this article FacebookXLinkedIn # Autoimmune Advocates Push for Health Insurance and Research Reform on Capitol Hill - [Advocacy](https://autoimmune.org/blog/category/advocacy/) People living with autoimmune disease often face significant barriers related to health insurance coverage, medication costs, and access to care. That’s why the Autoimmune Association brings patient advocates to Washington, D.C. each year to advance stronger autoimmune health policy and ensure lawmakers understand the real challenges patients face. **View the [highlights video](https://youtu.be/hPIRJ0eb0ls).** Last week, the Autoimmune Association brought passionate advocates from across the country to Capitol Hill for our 2026 Legislative Fly-In, a powerful day of advocacy focused on improving health policy for people living with autoimmune disease. ![project ()](https://autoimmune.org/wp-content/uploads/2026/03/project-3-768x1024.jpg "project ()") After a day of training and collaboration, these dedicated members of the autoimmune community headed to Capitol Hill, where they met with Congressional offices across the House and Senate. Their mission was simple but urgent: ensure that policymakers understand the real challenges people with autoimmune disease face and the policy solutions that can help. **Why Autoimmune Health Policy Matters** For millions of Americans, decisions made in Washington directly affect their ability to access treatment, afford medications, and navigate health insurance coverage. By sharing their personal experiences, advocates helped connect health policy decisions to the everyday realities of living with autoimmune disease. More than 50 million Americans live with autoimmune disease, a group of complex conditions in which the immune system mistakenly attacks the body’s own tissues. Many patients live with multiple autoimmune diseases and require ongoing care, specialized treatment, and lifelong medication. Despite their widespread impact, autoimmune diseases have historically received less research funding and policy attention than many other major health conditions. At the same time, patients frequently face barriers within the healthcare system, including: - High out-of-pocket costs for medications - Health insurance policies that delay access to treatment - Limited research funding to better understand autoimmune disease These challenges make strong health policy advocacy essential. By meeting directly with lawmakers and congressional health staff, advocates helped ensure the autoimmune community’s voice was heard during critical policy discussions. “The global incidence of autoimmunity is increasing, creating an urgent need to better understand these conditions and develop more effective methods of prevention, diagnosis, treatment, and ultimately a cure,” said Molly Murray, president and CEO of the Autoimmune Association. “We must also eliminate barriers that prevent patients from accessing care and treatments. Congress has an important role to play in improving the lives of millions of Americans living with autoimmune disease.” **Key Health Policy Priorities for Autoimmune Disease** During their meetings on Capitol Hill, advocates urged lawmakers to support several critical legislative priorities designed to improve healthcare access, strengthen health insurance protections, and advance autoimmune disease research. - **Invest in Autoimmune Disease Research![project](https://autoimmune.org/wp-content/uploads/2026/03/project-939x1024.jpg "project")** Advocates called on Congress to fully fund the [National Institutes of Health (NIH)](https://autoimmune.org/research/oadr/) for FY27. Federal investment in research is essential for improving diagnosis, understanding the causes of autoimmune disease, developing new treatments, and ultimately finding cures. Greater research funding also supports studies exploring why autoimmune diseases develop and why many patients live with multiple autoimmune conditions. - **Expand the Office of Autoimmune Disease Research (OADR) within the Office of Research on Women’s Health (ORWH)** Advocates brought new, innovative ways to expand the [OADR](https://autoimmune.org/research/oadr/) to accelerate autoimmune disease research and improve access to specialized care for patients. Advocates specifically raised: 1. 1. The expansion of the Autoimmune Disease Analysis Platform Testing Space (ADAPTS) to improve autoimmune disease research. 2. To scale, expand, and establish additional Autoimmunity Centers of Excellence (ACE). Additional ACEs will allow patients across the country to access innovative autoimmune treatments through clinical trials. 3. Increase the budget available to $120 million through the Office of Autoimmune Disease Research (OADR) for implementation of the strategic plan. This additional funding will significantly expand the current pipeline of autoimmune disease research. - **Reform Step Therapy Through the Safe Step Act** The Safe Step Act would improve [step therapy](https://autoimmune.org/advocacy/understanding-step-therapy/) protocols used by many health insurance plans. These policies often require patients to try and fail on insurer-preferred medications before accessing the treatment prescribed by their doctor. For people living with autoimmune disease, step therapy delays can mean worsening symptoms and unnecessary disease progression. The Safe Step Act would create a clear and transparent exceptions process, allowing patients to access medically necessary treatments more quickly. - **Reduce Medication Costs Through the HELP Copays Act** The Help Ensure Lower Patient (HELP) Copays Act addresses [copay accumulator programs](https://autoimmune.org/advocacy/accumulators-and-maximizers/) used by some health insurance plans. These programs prevent manufacturer copay assistance from counting toward a patient’s deductible or out-of-pocket maximum. As a result, patients can suddenly face thousands of dollars in additional costs once assistance runs out. For many people living with autoimmune disease who rely on specialty medications, these policies can create overwhelming financial strain. The HELP Copays Act would ensure that copay assistance counts toward patient cost-sharing obligations, helping reduce out-of-pocket costs. - **Strengthen the 340B Program Through the 340B ACCESS Act** Advocates also urged lawmakers to support the 340B ACCESS Act in the House and introduce similar legislation in the Senate. The [340B program](https://autoimmune.org/advocacy/understanding-340b/) allows certain healthcare providers to purchase medications at discounted prices, helping safety-net providers expand access to care for vulnerable patients. Strengthening this program helps ensure that more patients living with autoimmune disease can access the medications they need at more affordable prices. **![project ()](https://autoimmune.org/wp-content/uploads/2026/03/project-1-251x300.jpg "project ()")Turning Personal Stories into Policy Change** Throughout the day, advocates shared their personal journeys with autoimmune disease. Their stories helped lawmakers see how health policy decisions affect real people navigating the healthcare system. These conversations helped transform statistics into personal stories and reinforced the urgent need for policies that support people living with autoimmune disease. **Advocacy That Continues Beyond Capitol Hill** Meaningful change requires ongoing engagement. Patients, care partners, and supporters across the country can help move these priorities forward by contacting their representatives and urging them to support policies that improve care for people living with autoimmune disease. Visit our Autoimmune Legislative Action Center to: - Learn about key [autoimmune health policy priorities](https://autoimmune.org/advocacy/policy-priorities-principles/) - Understand how the [legislative process](https://autoimmune.org/advocacy/advocacy-101/) works - [Contact your elected officials](https://autoimmune.org/get-involved/help-change-policy/) in just a few minutes - Participate in advocacy campaigns that support the autoimmune community [Visit the Autoimmune Legislative Action Center](https://autoimmune.org/advocacy/)   **![project ()](https://autoimmune.org/wp-content/uploads/2026/03/project-2-1-217x300.jpg "project ()")Help Strengthen the Voice of the Autoimmune Community** Your support empowers autoimmune advocates, amplifies patient voices on Capitol Hill, and advances policies improving healthcare access and research. Donate today to strengthen our voice. [Donate Now](https://autoimmune.org/donate/) Share this article FacebookXLinkedIn ## Join our email list Receive the latest blog articles, news, and more right to your inbox! [Sign Up](https://go.pardot.com/l/864732/2021-01-25/mnz6b3) - ### Categories - [Advocacy](https://autoimmune.org/blog/category/advocacy/) - [Autoimmune Association News](https://autoimmune.org/blog/category/aarda-news/) - [Autoimmune Community Summit](https://autoimmune.org/blog/category/autoimmune-community-summit/) - [Autoimmune Heroes](https://autoimmune.org/blog/category/autoimmune-heroes/) - [COVID-19](https://autoimmune.org/blog/category/covid-19/) - [Featured Posts](https://autoimmune.org/blog/category/featured-posts/) - [Founder's Corner](https://autoimmune.org/blog/category/founders-corner/) - [Fundraising](https://autoimmune.org/blog/category/fundraising/) - [General Autoimmune](https://autoimmune.org/blog/category/general-autoimmune/) - [Immune System](https://autoimmune.org/blog/category/immune-system/) - [Raising Hope](https://autoimmune.org/blog/category/raising-hope/) - [Research](https://autoimmune.org/blog/category/research/) - [Resources](https://autoimmune.org/blog/category/resources/) - [Rheumatoid Disease](https://autoimmune.org/blog/category/rheumatoid-disease/) - [Sin categorizar](https://autoimmune.org/blog/category/sin-categorizar/) - [Uncategorized](https://autoimmune.org/blog/category/uncategorized/) - [Young Adult Advisory Council](https://autoimmune.org/blog/category/young-adult-advisory-council/) - ### ArchivesSelect Month/Year Month/Year October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 June 2023 May 2023 March 2023 January 2023 December 2022 September 2022 August 2022 July 2022 June 2022 May 2022 March 2022 February 2022 November 2021 August 2021 July 2021 April 2021 September 2020 April 2020 March 2020 November 2019 July 2019 February 2019 December 2018 August 2018 November 2017 March 2015 ## Related articles you might be interested in [![Autoimmune Association Image Do Not Touch](https://autoimmune.org/wp-content/uploads/2021/08/placeholder.jpg)](https://autoimmune.org/blog/step-therapy-prior-authorization/) ### [Policy Spotlight: Understanding Step Therapy and Prior Authorization](https://autoimmune.org/blog/step-therapy-prior-authorization/) October 6, 2026 [Advocacy](https://autoimmune.org/blog/category/advocacy/) Sign up for the 2026 Autoimmune Community Summit If you have an autoimmune condition or simply want to learn more about autoimmunity, join... [Learn More](https://autoimmune.org/blog/step-therapy-prior-authorization/) [![Autoimmune Association Image Do Not Touch](https://autoimmune.org/wp-content/uploads/2021/08/placeholder.jpg)](https://autoimmune.org/blog/autoimmune-association-backs-pbm-reform-bill/) ### [Autoimmune Association Backs PBM Reform Bill](https://autoimmune.org/blog/autoimmune-association-backs-pbm-reform-bill/) December 10, 2025 [Advocacy](https://autoimmune.org/blog/category/advocacy/) The Autoimmune Association Applauds Senate Finance Committee Chairman Mike Crapo (R-ID) and Ranking Member Ron Wyden (D-OR) for introducing the Pharmacy Benefit Manager... [Learn More](https://autoimmune.org/blog/autoimmune-association-backs-pbm-reform-bill/) [![Autoimmune Association Image Do Not Touch](https://autoimmune.org/wp-content/uploads/2021/08/placeholder.jpg)](https://autoimmune.org/blog/autoimmune-association-urges-federal-reform-of-340b-program-to-protect-patients/) ### [Autoimmune Association Urges Federal Reform of 340B Program to Protect Patients](https://autoimmune.org/blog/autoimmune-association-urges-federal-reform-of-340b-program-to-protect-patients/) October 23, 2025 [Advocacy](https://autoimmune.org/blog/category/advocacy/)   The Autoimmune Association welcomes the Senate HELP Committee’s hearing examining the growth and impact of the 340B Drug Pricing Program. For the... [Learn More](https://autoimmune.org/blog/autoimmune-association-urges-federal-reform-of-340b-program-to-protect-patients/) [![Autoimmune Association Image Do Not Touch](https://autoimmune.org/wp-content/uploads/2021/08/placeholder.jpg)](https://autoimmune.org/blog/meet-erika-battling-6-autoimmune-diseases-and-advocating-for-millions/) ### [Meet Erika: Battling 6 Autoimmune Diseases—and Advocating for Millions](https://autoimmune.org/blog/meet-erika-battling-6-autoimmune-diseases-and-advocating-for-millions/) June 24, 2025 [Advocacy](https://autoimmune.org/blog/category/advocacy/) A Mysterious Illness and Years Without Answers Erika’s story begins the way too many patients have experienced – with pain that didn’t have... [Learn More](https://autoimmune.org/blog/meet-erika-battling-6-autoimmune-diseases-and-advocating-for-millions/) ## Find more resources on autoimmunity Learn more about autoimmunity, diagnosis tips, how to find a physician, and more. [Learn More](https://autoimmune.org/resource-center/) ```json {"@context":"https:\/\/schema.org\/","@graph":[{"@context":"https:\/\/schema.org\/","@type":"VideoObject","@id":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/#videoobject","url":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/","headline":"Autoimmune Advocates Push for Reform on Capitol Hill","datePublished":"2026-03-30T10:00:04-04:00","dateModified":"2026-03-30T10:06:01-04:00","description":"Autoimmune advocates met with lawmakers to push for health insurance reform, lower medication costs, and increased research funding on Capitol Hill.","transcript":"People living with autoimmune disease often face significant barriers related to health insurance coverage, medication costs, and access to care. That\u2019s why the Autoimmune Association brings patient advocates to Washington, D.C.\u00a0each year to advance stronger autoimmune health policy and ensure lawmakers understand the real challenges patients face. View the highlights video. Last week, the Autoimmune Association brought passionate advocates from across the country to Capitol Hill for our 2026 Legislative Fly-In, a powerful day of advocacy focused on improving health policy for people living with autoimmune disease. After a day of training and collaboration, these dedicated members of the autoimmune community headed to Capitol Hill, where they met with\u00a0Congressional offices across the House and Senate. Their mission was simple but urgent: ensure that policymakers understand the real challenges people with autoimmune disease face and the policy solutions that can help. Why Autoimmune Health Policy Matters For millions of Americans, decisions made in Washington directly affect their ability to access treatment, afford medications, and navigate health insurance coverage. By sharing their personal experiences, advocates helped connect health policy decisions to the everyday realities of living with autoimmune disease. More than 50 million Americans live with autoimmune disease, a group of complex conditions in which the immune system mistakenly attacks the body\u2019s own tissues. Many patients live with multiple autoimmune diseases and require ongoing care, specialized treatment, and lifelong medication. Despite their widespread impact, autoimmune diseases have historically received less research funding and policy attention than many other major health conditions. At the same time, patients frequently face barriers within the healthcare system, including: \tHigh out-of-pocket costs for medications \tHealth insurance policies that delay access to treatment \tLimited research funding to better understand autoimmune disease These challenges make strong health policy advocacy essential. By meeting directly with lawmakers and congressional health staff, advocates helped ensure the autoimmune community\u2019s voice was heard during critical policy discussions. \u201cThe global incidence of autoimmunity is increasing, creating an urgent need to better understand these conditions and develop more effective methods of prevention, diagnosis, treatment, and ultimately a cure,\u201d said Molly Murray, president and CEO of the Autoimmune Association. \u201cWe must also eliminate barriers that prevent patients from accessing care and treatments. Congress has an important role to play in improving the lives of millions of Americans living with autoimmune disease.\u201d Key Health Policy Priorities for Autoimmune Disease During their meetings on Capitol Hill, advocates urged lawmakers to support several critical legislative priorities designed to improve healthcare access, strengthen health insurance protections, and advance autoimmune disease research. \tInvest in Autoimmune Disease Research Advocates called on Congress to fully fund the National Institutes of Health (NIH) for FY27. Federal investment in research is essential for improving diagnosis, understanding the causes of autoimmune disease, developing new treatments, and ultimately finding cures. Greater research funding also supports studies exploring why autoimmune diseases develop and why many patients live with multiple autoimmune conditions. \tExpand the Office of Autoimmune Disease Research (OADR) within the Office of Research on Women\u2019s Health (ORWH) Advocates brought new, innovative ways to expand the OADR to accelerate autoimmune disease research and improve access to specialized care for patients. Advocates specifically raised: \t \tThe expansion of the Autoimmune Disease Analysis Platform Testing Space (ADAPTS) to improve autoimmune disease research. \tTo scale, expand, and establish additional Autoimmunity Centers of Excellence (ACE). Additional ACEs will allow patients across the country to access innovative autoimmune treatments through clinical trials. \tIncrease the budget available to $120 million through the Office of Autoimmune Disease Research (OADR) for implementation of the strategic plan. This additional funding will significantly expand the current pipeline of autoimmune disease research. \tReform Step Therapy Through the Safe Step Act The Safe Step Act would improve step therapy protocols used by many health insurance plans. These policies often require patients to try and fail on insurer-preferred medications before accessing the treatment prescribed by their doctor. For people living with autoimmune disease, step therapy delays can mean worsening symptoms and unnecessary disease progression. The Safe Step Act would create a clear and transparent exceptions process, allowing patients to access medically necessary treatments more quickly. \tReduce Medication Costs Through the HELP Copays Act The Help Ensure Lower Patient (HELP) Copays Act addresses copay accumulator programs used by some health insurance plans. These programs prevent manufacturer copay assistance from counting toward a patient\u2019s deductible or out-of-pocket maximum. As a result, patients can suddenly face thousands of dollars in additional costs once assistance runs out. For many people living with autoimmune disease who rely on specialty medications, these policies can create overwhelming financial strain. The HELP Copays Act would ensure that copay assistance counts toward patient cost-sharing obligations, helping reduce out-of-pocket costs. \tStrengthen the 340B Program Through the 340B ACCESS Act Advocates also urged lawmakers to support the 340B ACCESS Act in the House and introduce similar legislation in the Senate. The 340B program allows certain healthcare providers to purchase medications at discounted prices, helping safety-net providers expand access to care for vulnerable patients. Strengthening this program helps ensure that more patients living with autoimmune disease can access the medications they need at more affordable prices. Turning Personal Stories into Policy Change Throughout the day, advocates shared their personal journeys with autoimmune disease. Their stories helped lawmakers see how health policy decisions affect real people navigating the healthcare system. These conversations helped transform statistics into personal stories and reinforced the urgent need for policies that support people living with autoimmune disease. Advocacy That Continues Beyond Capitol Hill Meaningful change requires ongoing engagement. Patients, care partners, and supporters across the country can help move these priorities forward by contacting their representatives and urging them to support policies that improve care for people living with autoimmune disease. Visit our Autoimmune Legislative Action Center to: \tLearn about key autoimmune health policy priorities \tUnderstand how the legislative process works \tContact your elected officials in just a few minutes \tParticipate in advocacy campaigns that support the autoimmune community Visit the Autoimmune Legislative Action Center   Help Strengthen the Voice of the Autoimmune Community Your support empowers autoimmune advocates, amplifies patient voices on Capitol Hill, and advances policies improving healthcare access and research. Donate today to strengthen our voice. Donate Now","name":"Autoimmune Advocates Push for Reform on Capitol Hill","uploadDate":"2026-03-30T10:00:04-04:00","thumbnailUrl":"https:\/\/i.ytimg.com\/vi\/hPIRJ0eb0ls\/hqdefault.jpg","author":{"@type":"Person","name":"Colleen Kmiecik","url":"https:\/\/autoimmune.org\/blog\/author\/colleen\/","sameAs":[],"image":{"@type":"ImageObject","url":"https:\/\/secure.gravatar.com\/avatar\/70669a23ed731bc2425150828e604d97af2f2091c5569da962b68d3158801569?s=96&d=mm&r=g","height":96,"width":96}},"contentUrl":"https:\/\/youtu.be\/hPIRJ0eb0ls","embedUrl":"https:\/\/youtu.be\/hPIRJ0eb0ls"}, {"@context":"https:\/\/schema.org\/","@type":"BreadcrumbList","@id":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https:\/\/autoimmune.org","name":"Autoimmune Association"}},{"@type":"ListItem","position":2,"item":{"@id":"https:\/\/autoimmune.org\/blog\/category\/advocacy\/","name":"Advocacy"}},{"@type":"ListItem","position":3,"item":{"@id":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/","name":"Autoimmune Advocates Push for Reform on Capitol Hill"}}]}, {"@context":"https:\/\/schema.org\/","@type":"BlogPosting","@id":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/#BlogPosting","url":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/","inLanguage":"en-US","mainEntityOfPage":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/","headline":"Autoimmune Advocates Push for Health Insurance and Research Reform on Capitol Hill","description":"Autoimmune advocates met with lawmakers to push for health insurance reform, lower medication costs, and increased research funding on Capitol Hill.","articleBody":"People living with autoimmune disease often face significant barriers related to health insurance coverage, medication costs, and access to care. That\u2019s why the Autoimmune Association brings patient advocates to Washington, D.C.\u00a0each year to advance stronger autoimmune health policy and ensure lawmakers understand the real challenges patients face. View the highlights video. Last week, the Autoimmune Association brought passionate advocates from across the country to Capitol Hill for our 2026 Legislative Fly-In, a powerful day of advocacy focused on improving health policy for people living with autoimmune disease. After a day of training and collaboration, these dedicated members of the autoimmune community headed to Capitol Hill, where they met with\u00a0Congressional offices across the House and Senate. Their mission was simple but urgent: ensure that policymakers understand the real challenges people with autoimmune disease face and the policy solutions that can help. Why Autoimmune Health Policy Matters For millions of Americans, decisions made in Washington directly affect their ability to access treatment, afford medications, and navigate health insurance coverage. By sharing their personal experiences, advocates helped connect health policy decisions to the everyday realities of living with autoimmune disease. More than 50 million Americans live with autoimmune disease, a group of complex conditions in which the immune system mistakenly attacks the body\u2019s own tissues. Many patients live with multiple autoimmune diseases and require ongoing care, specialized treatment, and lifelong medication. Despite their widespread impact, autoimmune diseases have historically received less research funding and policy attention than many other major health conditions. At the same time, patients frequently face barriers within the healthcare system, including: \tHigh out-of-pocket costs for medications \tHealth insurance policies that delay access to treatment \tLimited research funding to better understand autoimmune disease These challenges make strong health policy advocacy essential. By meeting directly with lawmakers and congressional health staff, advocates helped ensure the autoimmune community\u2019s voice was heard during critical policy discussions. \u201cThe global incidence of autoimmunity is increasing, creating an urgent need to better understand these conditions and develop more effective methods of prevention, diagnosis, treatment, and ultimately a cure,\u201d said Molly Murray, president and CEO of the Autoimmune Association. \u201cWe must also eliminate barriers that prevent patients from accessing care and treatments. Congress has an important role to play in improving the lives of millions of Americans living with autoimmune disease.\u201d Key Health Policy Priorities for Autoimmune Disease During their meetings on Capitol Hill, advocates urged lawmakers to support several critical legislative priorities designed to improve healthcare access, strengthen health insurance protections, and advance autoimmune disease research. \tInvest in Autoimmune Disease Research Advocates called on Congress to fully fund the National Institutes of Health (NIH) for FY27. Federal investment in research is essential for improving diagnosis, understanding the causes of autoimmune disease, developing new treatments, and ultimately finding cures. Greater research funding also supports studies exploring why autoimmune diseases develop and why many patients live with multiple autoimmune conditions. \tExpand the Office of Autoimmune Disease Research (OADR) within the Office of Research on Women\u2019s Health (ORWH) Advocates brought new, innovative ways to expand the OADR to accelerate autoimmune disease research and improve access to specialized care for patients. Advocates specifically raised: \t \tThe expansion of the Autoimmune Disease Analysis Platform Testing Space (ADAPTS) to improve autoimmune disease research. \tTo scale, expand, and establish additional Autoimmunity Centers of Excellence (ACE). Additional ACEs will allow patients across the country to access innovative autoimmune treatments through clinical trials. \tIncrease the budget available to $120 million through the Office of Autoimmune Disease Research (OADR) for implementation of the strategic plan. This additional funding will significantly expand the current pipeline of autoimmune disease research. \tReform Step Therapy Through the Safe Step Act The Safe Step Act would improve step therapy protocols used by many health insurance plans. These policies often require patients to try and fail on insurer-preferred medications before accessing the treatment prescribed by their doctor. For people living with autoimmune disease, step therapy delays can mean worsening symptoms and unnecessary disease progression. The Safe Step Act would create a clear and transparent exceptions process, allowing patients to access medically necessary treatments more quickly. \tReduce Medication Costs Through the HELP Copays Act The Help Ensure Lower Patient (HELP) Copays Act addresses copay accumulator programs used by some health insurance plans. These programs prevent manufacturer copay assistance from counting toward a patient\u2019s deductible or out-of-pocket maximum. As a result, patients can suddenly face thousands of dollars in additional costs once assistance runs out. For many people living with autoimmune disease who rely on specialty medications, these policies can create overwhelming financial strain. The HELP Copays Act would ensure that copay assistance counts toward patient cost-sharing obligations, helping reduce out-of-pocket costs. \tStrengthen the 340B Program Through the 340B ACCESS Act Advocates also urged lawmakers to support the 340B ACCESS Act in the House and introduce similar legislation in the Senate. The 340B program allows certain healthcare providers to purchase medications at discounted prices, helping safety-net providers expand access to care for vulnerable patients. Strengthening this program helps ensure that more patients living with autoimmune disease can access the medications they need at more affordable prices. Turning Personal Stories into Policy Change Throughout the day, advocates shared their personal journeys with autoimmune disease. Their stories helped lawmakers see how health policy decisions affect real people navigating the healthcare system. These conversations helped transform statistics into personal stories and reinforced the urgent need for policies that support people living with autoimmune disease. Advocacy That Continues Beyond Capitol Hill Meaningful change requires ongoing engagement. Patients, care partners, and supporters across the country can help move these priorities forward by contacting their representatives and urging them to support policies that improve care for people living with autoimmune disease. Visit our Autoimmune Legislative Action Center to: \tLearn about key autoimmune health policy priorities \tUnderstand how the legislative process works \tContact your elected officials in just a few minutes \tParticipate in advocacy campaigns that support the autoimmune community Visit the Autoimmune Legislative Action Center   Help Strengthen the Voice of the Autoimmune Community Your support empowers autoimmune advocates, amplifies patient voices on Capitol Hill, and advances policies improving healthcare access and research. Donate today to strengthen our voice. Donate Now","datePublished":"2026-03-30T10:00:04-04:00","dateModified":"2026-03-30T10:06:01-04:00","author":{"@type":"Organization","name":"Autoimmune Association","url":"https:\/\/autoimmune.org\/about-us\/","sameAs":[],"image":{"@type":"ImageObject","url":"https:\/\/secure.gravatar.com\/avatar\/70669a23ed731bc2425150828e604d97af2f2091c5569da962b68d3158801569?s=96&d=mm&r=g","height":96,"width":96}},"editor":{"@type":"Person","name":"Colleen Kmiecik","url":"https:\/\/autoimmune.org\/blog\/author\/colleen\/","sameAs":[],"image":{"@type":"ImageObject","url":"https:\/\/secure.gravatar.com\/avatar\/70669a23ed731bc2425150828e604d97af2f2091c5569da962b68d3158801569?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Autoimmune Association","url":"https:\/\/autoimmune.org","logo":"https:\/\/autoimmune.org\/wp-content\/uploads\/2021\/08\/logo-horizontal.svg"},"image":[{"@type":"ImageObject","url":"https:\/\/autoimmune.org\/wp-content\/uploads\/2026\/03\/project-3-768x1024-1200x675.jpg","width":1200,"height":675,"caption":"project ()","@id":"https:\/\/autoimmune.org\/blog\/autoimmune-advocacy-capitol-hill-reform\/#primaryimage"},{"@type":"ImageObject","url":"https:\/\/autoimmune.org\/wp-content\/uploads\/2026\/03\/project-939x1024.jpg","width":939,"height":1024,"caption":"project"},{"@type":"ImageObject","url":"https:\/\/autoimmune.org\/wp-content\/uploads\/2026\/03\/project-1-251x300.jpg","width":251,"height":300,"caption":"project ()"},{"@type":"ImageObject","url":"https:\/\/autoimmune.org\/wp-content\/uploads\/2026\/03\/project-2-1-217x300.jpg","width":217,"height":300,"caption":"project ()"}]}, {"@type":"NGO","@id":"https:\/\/autoimmune.org\/#ngo","name":"Autoimmune Association","description":"The Autoimmune Association serves autoimmune patients through research, advocacy for healthcare access, and collaboration across autoimmune diseases. Founded in 1991 as the American Autoimmune Related Diseases Association (AARDA), it now reaches over 60 countries.","url":"https:\/\/autoimmune.org","address":{"streetAddress":"19176 Hall Road, Suite 130","addressLocality":"Clinton Township","addressRegion":"MI","addressCountry":"US","postalCode":"48038"},"logo":"https:\/\/autoimmune.org\/wp-content\/uploads\/2021\/08\/logo-horizontal.svg","image":"https:\/\/autoimmune.org\/wp-content\/uploads\/2021\/08\/logo-horizontal.svg","founder":"Virginia T. Ladd","foundingDate":"1991","knowsAbout":"Autoimmune disease, autoimmune research, patient advocacy","sameAs":["https:\/\/www.facebook.com\/Autoimmunity","https:\/\/x.com\/AutoimmuneAssoc","https:\/\/www.linkedin.com\/company\/autoimmuneassociation\/"],"contactPoint":{"@type":"ContactPoint","contactType":"customer service","telephone":"+15867763900","email":"hello@autoimmune.org"},"@context":"https:\/\/schema.org","telephone":"+15867763900","email":"hello@autoimmune.org"}]} ```